ENHANCED DRUG DELIVERY
Live / Applied — Third extension granted (statement of use) (as of 27 Feb 2026)
What this means for you
Not registered yet, but its 07 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97783585
- Mark type
- Stylized text
- Filed
- 07 Feb 2023
- Published for opposition
- 03 Sept 2024
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of retinal diseases
- Class 042 — Scientific and technological services: research and development services in the field of retinal diseases; conducting clinical trials for others in the field of retinal diseases
Owner
- Vinci Pharmaceuticals, Inc., Avon by the Sea, NJ, US
- Vinci Pharmaceuticals, Inc., Avon by the Sea, NJ, US
Prosecution history
- 28 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2026 — SOU EXTENSION 3 GRANTED
- 27 Feb 2026 — SOU EXTENSION 3 FILED
- 27 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Aug 2025 — SOU EXTENSION 2 GRANTED
- 27 Aug 2025 — SOU EXTENSION 2 FILED
- 27 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Mar 2025 — SOU EXTENSION 1 GRANTED
- 28 Feb 2025 — SOU EXTENSION 1 FILED
- 28 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2024 — PUBLISHED FOR OPPOSITION